Pain Management

Top Story

FDA warns against use of kratom

FDA warns against use of kratom
November 14, 2017

The FDA issued a warning today about the potentially fatal risks linked to kratom, a plant-based product from Asia that the agency said is used to treat medical conditions such as pain, anxiety and depression, and used recreationally for its euphoric effects.

“I want to be clear on one fact: There are currently no FDA-approved therapeutic uses of kratom. Moreover, the FDA has evidence to show that there are significant safety issues associated with its use,” FDA Commissioner Scott Gottlieb, MD, said in a statement, adding that kratom’s effects mirror those of opioids, and carries similar risks for abuse, addiction and in some cases, death.

Meeting News

Pre-surgical patients with osteoarthritis commonly use opioids to manage pain

November 7, 2017
SAN DIEGO — Thirty percent of patients with end-stage knee, hip or spine osteoarthritis used opioids to manage chronic pain before surgery, according to data…

Generational, bureaucratic obstacles fuel opioid crisis

October 18, 2017
Opioid abuse is taking a catastrophic toll, with recent CDC data attributing 91 deaths a day to the epidemic. Further, in 2015, 63% of the 52,404 drug overdose deaths…
Meeting NewsVideo

VIDEO: Orthopedists should use multimodal pain medication early vs opioids for patients with musculoskeletal injuries

October 13, 2017
VANCOUVER, British Columbia — At the Orthopaedic Trauma Association Annual Meeting, William T. Obremskey, MD, discussed the opioid crisis in the United
More Headlines »